TOP >> UNIVERSITY OF MINNESOTA >> Pharmaceutical sciences
 
Browse Institutions
You are viewing titles for UNIVERSITY OF MINNESOTA in the Pharmaceutical sciences available through the UMI Dissertations & Thesis Gradwoorks site
 
Evaluation of Eukaryotic Initiation Factor 4E (eIF4E) Antagonist 4Ei-1 in Mammalian Breast Cancer and Lung Cancer Cells : Chemosensitizaiton with Low Cytotoxicity
Identifying the medication-related needs of American Indian elders in an urban setting
 
Enhanced delivery of anti-retroviral agents to the CNS: Effect of pluronics
Targeted delivery of anti-retroviral nucleosides: Role of breast cancer resistance protein
 
Influence of copayment differential between generic and preferred brand prescription drugs on generic fill rate
Studies on human arylamine N-acetyltransferases
 
Active efflux transport and CNS distribution of the novel antifolate pemetrexed
Essays in pharmaceutical economics
 
Application of an active comparator-based benefit-risk assessment in evaluating clinical trial design features of a new chemical entity using a Bayesian decision-theoretic framework
Demonstration of pharmacometric applications to anti-infective chemotherapy
 
Solute crystallization in the frozen and freeze-dried systems: Inhibition of crystallization to enhance pharmaceutical stability
Pharmacometric modeling of anti-cancer agents: Application to gemcitabine, PQIP and irinotecan
 
Intranasal and rectal diazepam for rescue therapy: Assessment of pharmacokinetics and tolerability
Targeted drugs and market failure: The case of BiDil(RTM)
 
Identification and Characterization of Carrier Transport Systems Influencing Agmatine Disposition
Effects of competition on governance choice and project performance: Evidence from clinical trials in the biotechnology industry
 
Development of Intravenous Topiramate for Neuroprotection and Seizure Control in Neonates
Impact of anthropomorphic images and narration styles in promotional messages regarding generic prescription drugs
 
Improving delivery of molecularly targeted agents to glioma
Educating for Action: Understanding the Development of Pharmaceutical Care Practitioners
 
Accelerating development of treatments for trigeminal neuralgia using intranasal delivery and a novel behavioral screening device for rats
Mechanisms and analysis of the CNS distribution of cediranib, a molecularly-targeted anti-angiogenic agent
 
Essays on Market Dynamics and State Laws
Medication risk management in high risk populations: An evaluation of cardiovascular risks associated with thiazolidinedione use in patients with chronic kidney disease
 
Regulating the unknown: Managing the occupational health risks of nanomedical technologies and nanopharmaceuticals in the research laboratory
Association of genetic and nongenetic variabilities with phenytoin and carbamazepine response phenotypes
 
The medication experience of people living with HIV: From the understanding of the meanings of medication to the development of a conceptual framework of medication experience
Sectoral and geographic mobility of the pharmacist workforce: Trends and determinants
 
Examining and improving the chemopreventive efficacy of curcumin
Development of effective anti-cancer agents targeting drug-resistant malignancies
 
Targeted Delivery of Polymer Vesicles Functionalized with Fibronectin Mimetic Peptides to Cancer Cells
Pharmacometric analyses of anti-epileptic drugs in elderly patients: Applications to carbamazepine, gabapentin, and topiramate
 
Pharmacometric analyses of lamotrigine in special populations: Application to pregnant women, younger adult and elderly epilepsy patients
Application of Pharmacometric Methods to Studies of Antiviral Prophylaxis After Solid Organ Transplantation
 
Quantitation of the metabolic activation of phenanthrene in smokers: Potential use in the assessment of lung cancer susceptibility
Improving delivery of elacridar to enhance efficacy of molecularly-targeted agents in treatment of glioblastoma
 
The Relationship Between Overall Utilization And Settlements Involving Off-Label Promotion Of Prescription Drugs
Medication therapy management (MTM): A tool for optimizing clinical and economic outcomes in the management of chronic diseases